BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharafi H, Alavian SM. The Rising Threat of Hepatocellular Carcinoma in the Middle East and North Africa Region: Results From Global Burden of Disease Study 2017. Clin Liver Dis (Hoboken) 2019;14:219-23. [PMID: 32015873 DOI: 10.1002/cld.890] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Pourkarim M, Nayebzadeh S, Alavian SM, Hataminasab SH. Digital Marketing: A Unique Multidisciplinary Approach towards the Elimination of Viral Hepatitis. Pathogens 2022;11:626. [DOI: 10.3390/pathogens11060626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Athamneh RY, Arıkan A, Sayan M, Mahafzah A, Sallam M. Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa. Pathogens 2021;10:1333. [PMID: 34684283 DOI: 10.3390/pathogens10101333] [Reference Citation Analysis]
3 Ismail F, Elsayed AG, El-Garawani I, Abdelsameea E. Cancer incidence in the Tobruk area, eastern Libya: first results from Tobruk Medical Centre. Epidemiol Health 2021;:e2021050. [PMID: 34412449 DOI: 10.4178/epih.e2021050] [Reference Citation Analysis]
4 Alqahtani SA, Sanai FM, Alolayan A, Abaalkhail F, Alsuhaibani H, Hassanain M, Alhazzani W, Alsuhaibani A, Algarni A, Forner A, Finn RS, Al-Hamoudi WK. Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma. Saudi J Gastroenterol 2020;26:S1-S40. [PMID: 33078723 DOI: 10.4103/sjg.SJG_477_20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
5 Yu B, Mamedov R, Fuhler GM, Peppelenbosch MP. Drug Discovery in Liver Disease Using Kinome Profiling. Int J Mol Sci 2021;22:2623. [PMID: 33807722 DOI: 10.3390/ijms22052623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Al-busafi SA, Alnaamani K. Hepatitis C-Induced Hepatocellular Carcinoma in the Middle East. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_17] [Reference Citation Analysis]
7 Mahmoud D, Mohammed MA, Zeidan Y, Shamseddine A. Radiotherapy for Hepatocellular Carcinoma. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_11] [Reference Citation Analysis]
8 Cherradi Y. Hepatocellular Carcinoma in Morocco. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_22] [Reference Citation Analysis]
9 Hashim MJ, Rizvi SS, Khan G. Hepatocellular Carcinoma in the United Arab Emirates. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_6] [Reference Citation Analysis]
10 Carr BI. Future Directions. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_26] [Reference Citation Analysis]
11 Yılmaz Y, Batur T, Korhan P, Öztürk M, Atabey N. Targeting c-Met and AXL Crosstalk for the Treatment of Hepatocellular Carcinoma. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_21] [Reference Citation Analysis]
12 Shiha G, Alswat K, Al Khatry M, Sharara AI, Örmeci N, Waked I, Benazzouz M, Al-Ali F, Hamed AE, Hamoudi W, Attia D, Derbala M, Sharaf-Eldin M, Al-Busafi SA, Zaky S, Bamakhrama K, Ibrahim N, Ajlouni Y, Sabbah M, Salama M, Anushiravani A, Afredj N, Barakat S, Hashim A, Fouad Y, Soliman R. Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa. Lancet Gastroenterol Hepatol 2021;6:57-64. [PMID: 33181119 DOI: 10.1016/S2468-1253(20)30213-2] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 33.0] [Reference Citation Analysis]